Kati Kämpjärvi is the Senior Manager, Variant Science, in the Clinical Interpretation (CI) Team. She collaborates with CI directors, associate laboratory directors, and managers, and takes the leads to maintain and develop high-quality-clinical interpretation processes, reporting policies, and tools. She oversees the CI production process and supports the Genomic Variant Science Team to ensure high-quality variant curation and clinical interpretation of the genetic data. She also works in a Genetic Liaison role, supporting Client Services and Clinical Genomic Services (CGS) teams with requests concerning clinical interpretation. Kati received her PhD in tumor genetics from the University of Helsinki in 2016 and has experience working in both research and clinical laboratory settings. She joined Blueprint Genetics in 2017 and has worked as a geneticist and team lead before her current position. As a geneticist her primary focus was in analyzing genetic panels in ophthalmology.